Pfizer 'aunches 'An Accord for a Healthier World' to improve health equity for 1.2 billion people living in 45 lower-income countries
- Details
- Category: Pfizer

Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
- Details
- Category: Roche

Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine
- Details
- Category: Business
The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.
It is estimated that in 2021 the vaccine, the most widely used against COVID-19 in the US, prevented 8.7 million symptomatic cases of the virus, as well as 690,000 hospitalizations and more than 110,000 deaths.
Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
- Details
- Category: Business

Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
- Details
- Category: Roche

Pfizer to acquire Biohaven Pharmaceuticals
- Details
- Category: Pfizer

Foundation S: Sanofi's new philanthropic spearhead
- Details
- Category: Sanofi

More Pharma News ...
- Pfizer shares top-line results from Phase 2/3 EPIC-PEP study of PAXLOVID™ for post-exposure prophylactic use
- SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study
- Pfizer and Biohaven's VYDURA® (rimegepant) granted first ever marketing authorization by European Commission for both acute treatment of migraine and prophylaxis of episodic migraine
- Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
- Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
- GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
- Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board